Dr. Gena H. Volas-Redd

Hematology Oncology | Hematology | Oncology
790 Church St Ne, Suite 335, 
Marietta, GA 
Accepting New Patients
790 Church St Ne, Suite 335, 
Marietta, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Gena Volas-Redd is a Hematologist Oncology specialist and a Hematologist in Marietta, Georgia. Dr. Volas-Redd is rated as an Experienced provider by MediFind in the treatment of Carney Complex. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Astrocytoma, and Gliosarcoma. Dr. Volas-Redd is currently accepting new patients.

Her clinical research consists of co-authoring 2 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in GA
Hospital Affiliations
Piedmont Mountainside Hospital Inc
Wellstar Paulding Medical Center
Northside Hospital Cherokee
Wellstar Kennestone Regional Medical Center
Northside Hospital
Languages Spoken
English
Greek
Spanish
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

NSH CANCER INSTITUTE PROFESSIONAL SERVICES G LLC
790 Church St Ne, Suite 335, Marietta, GA 30060
Other Locations
NSH CANCER INSTITUTE PROFESSIONAL SERVICES G LLC
1045 Southcrest Dr, Suite 200, Stockbridge, GA 30281

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Change in Relative Cerebral Blood Volume as a Biomarker for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
Change in Relative Cerebral Blood Volume as a Biomarker for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: September 09, 2025
Intervention Type: Diagnostic test
Study Phase: Not Applicable
A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy
A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy
Enrollment Status: Completed
Publish Date: August 22, 2025
Intervention Type: Drug
Study Drug: Ramipril
Study Phase: Phase 2
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
Enrollment Status: Completed
Publish Date: January 27, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
EPIK-B4: A Phase II, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR During Treatment With Alpelisib (BYL719) in Combination With Fulvestrant in Participants With HR+, HER2-, Advanced Breast Cancer With a PIK3CA Mutation Following Progression on/After Endocrine-based Therapy
EPIK-B4: A Phase II, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR During Treatment With Alpelisib (BYL719) in Combination With Fulvestrant in Participants With HR+, HER2-, Advanced Breast Cancer With a PIK3CA Mutation Following Progression on/After Endocrine-based Therapy
Enrollment Status: Terminated
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drugs: Alpelisib, Fulvestrant, Metformin, Dapagliflozin
Study Phase: Phase 2
A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 26, 2024
Intervention Type: Other, Procedure, Biological, Drug
Study Drugs: Atezolizumab, Paclitaxel, Pertuzumab, Trastuzumab
Study Phase: Phase 3
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Enrollment Status: Terminated
Publish Date: April 05, 2023
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE)in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer (The METRIC Study)
A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE)in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer (The METRIC Study)
Enrollment Status: Completed
Publish Date: March 08, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

2 Total Publications

Efficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study.
Efficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study.
Journal: Clinical breast cancer
Published: November 14, 2018
Similar Doctors
Advanced in Carney Complex
Dr. Benjamin R. Wilson
Gynecologic Oncology | Oncology
Advanced in Carney Complex
Dr. Benjamin R. Wilson
Gynecologic Oncology | Oncology

Piedmont Athens Specialty Care LLC

340 Exchange Blvd, 
Bethlehem, GA 
 (46.1 miles away)
678-963-7171
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Benjamin Wilson is a Gynecologic Oncologist and an Oncologist in Bethlehem, Georgia. Dr. Wilson is rated as an Advanced provider by MediFind in the treatment of Carney Complex. His top areas of expertise are Lump in the Abdomen, Angiomyoma, Uterine Fibroids, and Endometritis. Dr. Wilson is currently accepting new patients.

Experienced in Carney Complex
Dr. Damien M. Hansra
Oncology | Hematology Oncology
Experienced in Carney Complex
Dr. Damien M. Hansra
Oncology | Hematology Oncology

Piedmont Providers LLC

1279 Hwy 54 W, Suite 100, 
Fayetteville, GA 
 (33.4 miles away)
770-719-5710
Languages Spoken:
English, Filipino, French, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Damien Hansra is an Oncologist and a Hematologist Oncology provider in Fayetteville, Georgia. Dr. Hansra is rated as a Distinguished provider by MediFind in the treatment of Carney Complex. His top areas of expertise are Pleuropulmonary Blastoma, Breast Cancer, Chronic B-Cell Leukemia (CBCL), and Angiosarcoma. Dr. Hansra is currently accepting new patients.

Experienced in Carney Complex
Dr. Cyril O. Spann
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Experienced in Carney Complex
Dr. Cyril O. Spann
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

Piedmont Providers LLC

1800 Howell Mill Rd Nw, Suite 785, 
Atlanta, GA 
 (13.9 miles away)
404-425-1380
Languages Spoken:
English, Filipino, French
See accepted insurances
Accepting New Patients
Offers Telehealth

Cyril Spann is a Gynecologic Oncologist and an Oncologist in Atlanta, Georgia. Dr. Spann is rated as a Distinguished provider by MediFind in the treatment of Carney Complex. His top areas of expertise are Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Bladder Reconstruction, and Oophorectomy. Dr. Spann is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Volas-Redd's expertise for a condition
ConditionClose
    View All 19 Distinguished Conditions
    View All 45 Advanced Conditions
    View All 180 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile